BBVA USA’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$2K Sell
71
-229
-76% -$6.45K ﹤0.01% 930
2021
Q2
$9K Buy
+300
New +$9K ﹤0.01% 872